Full Name | Patrick Bogard |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 46 Years |
Location | 4955 F Street, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386693455 | NPI | - | NPPES |
220022265 | Other | NE | RR MEDICARE |
44195 | Other | IA | BCBS |
Facility Name | Location | Facility Type |
---|---|---|
Chi Health Bergan Mercy | Omaha, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alegent Creighton Clinic | 1951210418 | 827 |
Alegent Creighton Clinic | 1951210418 | 827 |
News Archive
J. Eric Bubbers, PhD, of the Saban Research Institute at Childrens Hospital Los Angeles, has received a $410,000 grant from Phase One Foundation. The award will fund a "first in childhood leukemia" multi-site study in children with relapsed or refractory acute lymphocytic leukemia (ALL) or acute myelogenous leukemia (AML). Dr. Bubbers is the administrative director of Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL), an academic research consortium consisting of 33 member institutions in four countries.
UK-based Global Clinical Research Organisation (CRO), ClinTec International has unveiled a significant expansion into the US marketplace, with the launch of its New York office and the appointment of Susan Pavone, Associate Director of US Business Operations.
A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck.
Delcath Systems, Inc. has announced that the first fifty percent (46 of 92) of patients have been enrolled in the Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver.
› Verified 6 days ago
Entity Name | Alegent Creighton Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
J. Eric Bubbers, PhD, of the Saban Research Institute at Childrens Hospital Los Angeles, has received a $410,000 grant from Phase One Foundation. The award will fund a "first in childhood leukemia" multi-site study in children with relapsed or refractory acute lymphocytic leukemia (ALL) or acute myelogenous leukemia (AML). Dr. Bubbers is the administrative director of Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL), an academic research consortium consisting of 33 member institutions in four countries.
UK-based Global Clinical Research Organisation (CRO), ClinTec International has unveiled a significant expansion into the US marketplace, with the launch of its New York office and the appointment of Susan Pavone, Associate Director of US Business Operations.
A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck.
Delcath Systems, Inc. has announced that the first fifty percent (46 of 92) of patients have been enrolled in the Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Patrick Bogard, MD Po Box 4907, Omaha, NE 68104 Ph: (800) 831-2402 | Patrick Bogard, MD 4955 F Street, Omaha, NE 68117 Ph: (402) 717-2871 |
News Archive
J. Eric Bubbers, PhD, of the Saban Research Institute at Childrens Hospital Los Angeles, has received a $410,000 grant from Phase One Foundation. The award will fund a "first in childhood leukemia" multi-site study in children with relapsed or refractory acute lymphocytic leukemia (ALL) or acute myelogenous leukemia (AML). Dr. Bubbers is the administrative director of Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL), an academic research consortium consisting of 33 member institutions in four countries.
UK-based Global Clinical Research Organisation (CRO), ClinTec International has unveiled a significant expansion into the US marketplace, with the launch of its New York office and the appointment of Susan Pavone, Associate Director of US Business Operations.
A laboratory study by researchers at Albert Einstein College of Medicine of Yeshiva University suggests that an anti-cancer compound studied for treating blood cancers may also help in treating cancers of the head and neck.
Delcath Systems, Inc. has announced that the first fifty percent (46 of 92) of patients have been enrolled in the Phase III clinical trial treating metastatic cutaneous and ocular melanoma to the liver.
› Verified 6 days ago
Audrey J Lazenby, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4186 Fax: 402-559-6018 | |
Shane K. Kohl, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Stanley J Radio, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 988102 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-4186 Fax: 402-559-6018 | |
Christine Petricek Hans, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Dr. Diana L Nevins, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 8303 Dodge St, Omaha, NE 68114 Phone: 402-354-4540 Fax: 402-354-4535 | |
Dr. Marc R Hapke, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 909 N 96th St, Suite 201, Omaha, NE 68114 Phone: 402-330-4555 Fax: 402-934-0945 | |
Bryan Scott Teruya, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 4101 Woolworth Ave, Department Of Pathology, Omaha, NE 68105 Phone: 402-995-3218 |